Can glucose-lowering medications improve outcomes in non-diabetic heart failure patients? A Bayesian network meta-analysis.
Trevor YeongAaron Shengting MaiOliver Z H LimCheng Han NgYip Han ChinPhoebe TayChaoxing LinMark MuthiahChin Meng KhooMayank DalakotiPoay-Huan LohMark ChanTiong-Cheng YeoRoger FooRaymond WongNicholas W S ChewWeiqin LinPublished in: ESC heart failure (2022)
and NT-proBNP in non-diabetic HF patients. Further large-scale prospective studies are needed to confirm these preliminary findings.
Keyphrases
- ejection fraction
- systematic review
- end stage renal disease
- type diabetes
- newly diagnosed
- chronic kidney disease
- case control
- wound healing
- prognostic factors
- peritoneal dialysis
- heart failure
- randomized controlled trial
- meta analyses
- patient reported outcomes
- metabolic syndrome
- skeletal muscle
- insulin resistance
- adipose tissue
- weight loss
- acute heart failure